Editorial comment on: Von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1.
Kassouf
Wassim
W
D002292:Carcinoma, Renal Cell / Q000235:genetics; D066246:ErbB Receptors / Q000502:physiology*; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics; D048369:MAP Kinase Kinase 1 / Q000502:physiology*; D051057:Proto-Oncogene Proteins c-akt / Q000502:physiology*; D015398:Signal Transduction; D006623:von Hippel-Lindau Disease / Q000235:genetics
C512478:EGFR protein, human; D066246:ErbB Receptors; D051057:Proto-Oncogene Proteins c-akt; D048369:MAP Kinase Kinase 1; C482125:MAP2K1 protein, human